Neuropathology and Amyloid-β Spectrum in a Bapineuzumab Immunotherapy Recipient

The field of Alzheimer’s disease (AD) research eagerly awaits the results of a large number of Phase III clinical trials that are underway to investigate the effectiveness of anti-amyloid-β (Aβ) immunotherapy for AD. In this case report, we review the pertinent clinical history, examine the neuropat...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Roher, Alex E., Maarouf, Chera L., Daugs, Ian D., Kokjohn, Tyler A., Hunter, Jesse M., Sabbagh, Marwan N., Beach, Thomas G.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2011
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3172868/
https://ncbi.nlm.nih.gov/pubmed/21263194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-2011-101809
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky